Clinical Trial Update: Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing long-term efficacy of bempedoic acid in patients with hypercholesterolemia at high cardiovascular risk; results posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia

Drugs mentioned

• Bempedoic Acid (bempedoic acid)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Hypercholesterolemia, Atherosclerotic Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-04-27